Biomerica (BMRA) Equity Ratio (2011 - 2026)

Biomerica has disclosed Equity Ratio across 16 years of filings, most recently posting 0.68 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 0.68, down 9.37% year-over-year; the trailing twelve-month figure through Feb 2026 was 0.68 (down 9.37% YoY), and the FY2025 annual result was 0.69, down 3.05% from the prior year.
• Equity Ratio came in at 0.68 for Q1 2026 at Biomerica, down from 0.74 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.81 in Q3 2023 to a low of 0.56 in Q1 2022.
• The 5-year median for Equity Ratio is 0.73 (2022), against an average of 0.73.
• Across the five-year window, Equity Ratio slumped 30.03% in 2022 and jumped 31.25% in 2023, its largest moves.
• Biomerica's Equity Ratio stood at 0.73 in 2022, then advanced by 8.47% to 0.79 in 2023, then decreased by 11.35% to 0.7 in 2024, then climbed by 4.54% to 0.74 in 2025, then fell by 7.48% to 0.68 in 2026.
• The last three Equity Ratio figures came in at 0.68 (Q1 2026), 0.74 (Q4 2025), and 0.75 (Q3 2025), per Business Quant data.